Funding Received
$10 Million in 1 Round from 2 Investors
Most Recent Funding
$10 Million Series A on November 22, 2013
Description:
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.
Categories:
Biotechnology

Company Details

Update

Sitari Pharmaceuticals a biotech startup was founded by Avalon with intellectual property from Stanford University.

Funding Rounds (1) - $10M

Update

Investors (2)

Update
  • 3bb7a24177ecb3d281552620fa98aeda

    GlaxoSmithKline

    HIV, TB pharmaceuticals
  • 81dd9f355a80474e8fd113c5e40e8612

    Avalon Ventures

    Avalon Ventures is an early stage venture capital fund focused on information technology and life...